SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-042049
Filing Date
2022-02-14
Accepted
2022-02-14 16:56:51
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND V GP MANAGER, LTD.OMEGA FUND V GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d283094dsc13ga.htm SC 13G/A 134328
2 EX-99.1 d283094dex991.htm EX-99.1 7856
3 EX-99.2 d283094dex992.htm EX-99.2 12637
  Complete submission text file 0001193125-22-042049.txt   156533
Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund V, L.P. (Filed by) CIK: 0001641354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Subject) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91053 | Film No.: 22634051
SIC: 2834 Pharmaceutical Preparations